Prothena Corp. (PRTA) Tops Q3 EPS by 2c

Prothena Corp. (NASDAQ: PRTA) reported Q3 EPS of ($1.37), $0.02 better than the analyst estimate of ($1.39). Revenue for the quarter came in at $219 thousand versus the consensus estimate of $250 thousand.

Net cash used in operating and investing activities was $18.3 million in the third quarter and $94.8 million for the first nine months of 2017; quarter-end cash and restricted cash position of $460.1 million, provides funding to advance diverse pipeline.

For earnings history and earnings-related data on Prothena Corp. (PRTA) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• Edwards Lifesciences (EW) Tops Q1 EPS by 2c; offers guidance
• Allison Transmission (ALSN) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY24 Revenue Guidance